Health Care

Filter By:



Research Team

Use comma-separated ID numbers for each author

Support the Hoover Institution

Join the Hoover Institution's community of supporters in advancing ideas defining a free society.

Support Hoover

In the News

Could Health Care Come Back To Hurt GOP In Midterms?

quoting Lanhee J. Chenvia Real Clear Politics
Friday, March 30, 2018

Eight years after Obamacare became the law of the land and set the stage for the Republican takeover of the House of Representatives, the issue of health care could come back to complicate GOP hopes of holding that majority in this year's midterms.

In the News

Hoover Archives Materials Added To The American Archive Of Public Broadcasting

Friday, March 30, 2018

The partnership adds 6,203 audiovisual recordings from the Hoover Library & Archives to its Online Reading Room.

Analysis and Commentary

Why 'GMO' Is A Meaningless Term (And How To Fix That)

by Henry I. Millervia America's News HQ (Fox News)
Tuesday, March 27, 2018

There’s a saying in French, plus ça change, plus c'est la même chose, the more things change, the more they stay the same. We were reminded of that on the 30th anniversary of an op-ed about genetic engineering that we published in the Wall Street Journal when one of us (Dr. Young) headed the U.S. Food & Drug Administration and the other (Dr. Miller) was his special assistant.

In the News

Congress Right To Challenge FDA Veto Power Over Your Medical Options

quoting Henry I. Millervia News Max
Tuesday, March 27, 2018

As Henry I. Miller and Gregory Conko recently pointed out, the Second Circuit Court of Appeals in 2012 overturned the conviction of a pharmaceutical sales representative who told a doctor about off-label uses of Xyrem, a prescription drug manufactured by Orphan Medical, Inc. 


A&G Hr. 1 & 3 How To Get The Biggest Paycheck With Scott Atlas (29:14)

interview with Scott W. Atlasvia Armstrong and Getty
Monday, March 26, 2018

Hoover Institution fellow Scott Atlas discusses his CNN article, “Soaring Drug Prices? Here's How To Control Them.” 


Soaring Drug Prices? Here's How To Control Them

by Scott W. Atlasvia CNN
Wednesday, March 21, 2018

New Health and Human Services Secretary Alex Azar has identified his main priorities. At the top of his list is lowering prescription drug prices.


Scott Atlas: The Remnants Of Shipwrecked Obamacare Threaten The Republicans Without Remedies

interview with Scott W. Atlasvia The John Batchelor Show
Tuesday, March 20, 2018

Hoover Institution fellow Scott Atlas discusses his Hill article "Aggressive deregulation is the key for competition-based, health-care reform."


Aggressive Deregulation Is The Key For Competition-Based, Health-Care Reform

by Scott W. Atlasvia The Hill
Monday, March 19, 2018

Contrary to the prevailing narrative, health care reform is alive and progressing. The public only hears about a bungling Congress that cannot repeal and replace the Affordable Care Act, a law that is already imploding on its own. This administration continues to implement strategic deregulation that will lower the cost of medical care and insurance through competition.

In the News

Senators Seek Clearer View On Health-Care Prices

quoting Scott W. Atlasvia Bloomberg BNA
Thursday, March 15, 2018

Consumers may be able to get better information about health-care prices such as hospital visits or MRI tests under legislation being developed by a bipartisan group of senators.

Analysis and Commentary

‘Right To Try’ Unapproved Drugs Advances Personal Freedom -- But Risks Must Be Taken Into Account

by Henry I. Millervia Fox News
Tuesday, March 13, 2018

Several times recently, President Trump endorsed terminally ill patients’ “right to try” drugs not approved by the FDA: “Patients with terminal conditions, terminal illness, should have access to experimental treatment immediately that could potentially save their lives,” he said in the State of the Union speech.


Health Care Policy Working Group

The Working Group on Health Care Policy devises public policies that enable more Americans to get better value for their health care dollar and foster appropriate innovations that will extend and improve life.